At the end of follow-up, ROC curves based on the incidence of thrombophlebitis were plotted to evaluate the efficacy of HALP, albumin (ALB), NLR, and lactate dehydrogenase (LDH). This evidence concerns the gene NAT10 and Thrombophlebitis.